MP CARDIOFLOW-B (02160) Company Profile - Company Info, Industry & Management

返回 News Financials Shareholders Profile IPO ›

Industry

Medical Devices 0.46%

45 stocks in this industry

3 >7%

2 5~7%

1 3~5%

12 0~3%

8 0%

13 0~3%

4 3~5%

0 5~7%

2 >7%

Down 18 Up 19

Industry RankingsValue (HKD)Rank

ROE (Last FY)-7.34%31/49

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition

Brian Chang Executive Director

Chen Guoming Executive Director

Zhang Ruinian Executive Director

Philippe Wanstok Executive Director

Deng Aoyi Executive Director

Jonathan H. Chou Executive Director

Sun Zhixiang Executive Director

Hu Bingshan Executive Director

Mao Junxiang Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-08-26.

About this page

This page shows MP CARDIOFLOW-B (02160) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.

MP CARDIOFLOW-B 02160

Company Information

Industry

Management

MP CARDIOFLOW-B 02160·

Company Information

Industry

Management

MP CARDIOFLOW-B 02160